Occipital Nerve Stimulation (ONS) for the treatment of chronic headache syndromes by J Vesper et al.
POSTER PRESENTATION Open Access
Occipital Nerve Stimulation (ONS) for the
treatment of chronic headache syndromes
J Vesper1*, G Bara2, TM Kinfe2, S Schu2
From The European Headache and Migraine Trust International Congress
London, UK. 20-23 September 2012
Introduction
Migraine is highly prevalent along with the high percentage
of treatment-refractory cases. ONS may provide pain relief
for patients with otherwise refractory primary headache
disorders. It is more generally applicable than other
invasive methods.
Objectives
We therefore investigated ONS in a series of patients to
determine efficacy, complications and outcome.
Methods
We included a case series of 20 patients who had chronic
headaches for a duration of 5.3 y who underwent ONS
lead implantation (SJM, Octrode). Prior to surgery patients
had received conservative and surgical therapies including
antidepressants, occipital nerve blocks, opioids, cervical
posterior fusion (one patient), without success. 9 patients
suffered from chronic migraine, 1 had a history of thalamic
infarction, 1 patient suffered from cluster headache,
4 patients complained tension headache and 5 patients
with recurrent cervicozephalgia after spine surgery. Using a
midline approach two octrodes were placed subcutaneously
and positioned across the level of C1 using fluoroscopy.
Leads were placed under general anesthesia and externa-
lized for three days.
Results
Device dislocation was found in 3 cases. 16 patients men-
tioned significant relief of pain, so that they all underwent
insertion of the generator (eon MINI, SJM), in 3 patients
30% pain reduction was achieved, one patient did not ben-
efit. Decreases in pain led to an improvement in functional
capacity during the 3 months follow-up after implantation.
The mean VAS score changed from 8.2 ± 1.5 to 3.5 ± 1.3
at the 6 months follow-up. No complicaoccurred.
Discussion
The exact mechanism of neuromodulation in the tratment
of different headache syndromes remains unclear. ONS is
safe and efficacious in the treatment of medically intract-
able headaches conditions. Further investigations are
required to evaluate predictor for patient selection and
sstimulation setting among this crucial pain conditions.
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